nivolumab,ipilimumab
ono Pharmaceuticals,bms
['nivo', ' ipi ', 'tnbc', 'bellini', 'medsir']
excellent presented by at #esmo22: bellini trial (woo: nivo +/- ipi 4w before neoadjuvant ctx or surgery); early tnbc pts with tils showed activity of immune checkpoint inhibitors and favorable clinical response: 23% radiological response rate, 1 pcr and 1 near pcr. 
Bring your idea to life??Creating successful IITs & optimal drug development??Medica Scientia Innovation Research????????https://t.co/cciUf0lqpM